Cat. Number:

KL-0004R

Quantity size:

0.2ml

Concentration:

Anti-ACTH (7-23)抗體1mg/ml   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Anti-ACTH (7-23)抗體This gene encodes a polypeptide hormone precursor that undergoes extensive, tissue-specific, post-translational processing via cleavage by subtilisin-like enzymes known as prohormone convertases. There are eight potential cleavage sites within the polypeptide precursor and, depending on tissue type and the available convertases, processing may yield as many as ten biologically active peptides involved in diverse cellular functions. The encoded protein is synthesized mainly in corticotroph cells of the anterior pituitary where four cleavage sites are used; adrenocorticotrophin, essential for normal steroidogenesis and the maintenance of normal adrenal weight, and lipotropin beta are the major end products. In other tissues, including the hypothalamus, placenta, and epithelium, all cleavage sites may be used, giving rise to peptides with roles in pain and energy homeostasis, melanocyte stimulation, and immune modulation. These include several distinct melanotropins, lipotropins, and endorphins that are contained within the adrenocorticotrophin and beta-lipotropin peptides. Mutations in this gene have been associated with early onset obesity, adrenal insufficiency, and red hair pigmentation. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Jul 2008].

Also known as:

Anti-ACTH (7-23)抗體Adrenocorticotropic hormone; Adrenocorticotropin; Adrenocorticotropin Hormone; Alpha Melanocyte Stimulating Hormone; Beta Endorphin; Beta Lipotropin; Beta Melanocyte Stimulating Hormone; CLIP; Corticotropin; Corticotropin Like Intermediary Peptide; Corticotropin lipotropin precursor; Lipotropin Beta; Lipotropin Gamma; LPH; Melanotropin Alpha; Met Enkephalin; MSH; NPP; POC; POMC; Pro opiomelanocortin; Proopiomelanocortin.

Specificity:

Storage:

Anti-ACTH (7-23)抗體Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

Anti-ACTH (7-23)抗體ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.kl176Ra01 脂肪酶I(LIPI)多克隆抗體 Polyclonal Antibody to Likle I (LIPI)
kl175Hu01 脂肪酶H(LIPH)多克隆抗體 Polyclonal Antibody to Likle H (LIPH)
kl175Mu01 脂肪酶H(LIPH)多克隆抗體 Polyclonal Antibody to Likle H (LIPH)
kl386Hu01 脂蛋白脂酶(LIPD)多克隆抗體 Polyclonal Antibody to Likle, Lipoprotein (LIPD)
kl386Mu01 脂蛋白脂酶(LIPD)多克隆抗體 Polyclonal Antibody to Likle, Lipoprotein (LIPD)
kl386Ra01 脂蛋白脂酶(LIPD)多克隆抗體 Polyclonal Antibody to Likle, Lipoprotein (LIPD)
kl225Hu01 溶酶體酸脂肪酶A(LIPA)多克隆抗體 Polyclonal Antibody to Likle A, Lysosomal Acid (LIPA)
kl225Mu01 溶酶體酸脂肪酶A(LIPA)多克隆抗體 Polyclonal Antibody to Likle A, Lysosomal Acid (LIPA)
kl225Ra01 溶酶體酸脂肪酶A(LIPA)多克隆抗體 Polyclonal Antibody to Likle A, Lysosomal Acid (LIPA)
kl526Ge01 脂多糖(LPS)多克隆抗體 Polyclonal Antibody to Lipopolysaccharide (LPS)
kl082Hu01 層粘連蛋白γ1(LAMγ1)多克隆抗體 Polyclonal Antibody to Laminin Gamma 1 (LAMC1)
kl082Mu01 層粘連蛋白γ1(LAMγ1)多克隆抗體 Polyclonal Antibody to Laminin Gamma 1 (LAMC1)
kl082Ra01 層粘連蛋白γ1(LAMγ1)多克隆抗體 Polyclonal Antibody to Laminin Gamma 1 (LAMC1)
kl014Hu01 骨成型蛋白4(BMP4)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)